Chembio Diagnostic, Inc. (CEMI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Chembio Diagnostic, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013816
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Summary
Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes POC testing faster. Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. The company distributes its products through a network of distributors worldwide. Chembio is headquartered in Medford, the US.

Chembio Diagnostic, Inc. (CEMI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Chembio Diagnostic, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Chembio Diagnostic, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 7
Chembio Diagnostic, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Chembio Diagnostic, Inc., Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Chembio Diagnostic, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Chembio Diagnostic, Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
Chembio Diagnostics Acquires Rights to SURE CHECK(R) HIV 1/2 Assay From StatSure Diagnostic Systems 11
Partnerships 12
Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 12
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 13
Chembio Diagnostics Enters into Agreement with FIND 14
Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 15
Chembio Diagnostics Enters into Agreement with Perseus Science 16
Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 17
Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 18
Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 19
Equity Offering 20
Chembio Diagnostics to Raise up to USD21.2 Million in Public Offering of Shares 20
Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 21
Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million 23
Acquisition 24
Chembio Diagnostics Acquires RVR Diagnostics 24
Chembio Diagnostic, Inc. – Key Competitors 25
Chembio Diagnostic, Inc. – Key Employees 26
Chembio Diagnostic, Inc. – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Nov 08, 2017: Chembio Diagnostics Reports Third Quarter 2017 Financial Results 28
Aug 09, 2017: Chembio Diagnostics Reports Second Quarter 2017 Financial Results 30
May 09, 2017: Chembio Diagnostics Reports First Quarter 2017 Financial Results 32
Mar 07, 2017: Chembio Diagnostics Reports 2016 Financial Results 34
Nov 10, 2016: Chembio Diagnostics Reports Third Quarter 2016 Financial Results 36
Aug 11, 2016: Chembio Diagnostics Reports Second Quarter 2016 Financial Results 39
Jul 25, 2016: Chembio Diagnostics Announces Preliminary Second Quarter 2016 Results 42
May 12, 2016: Chembio Diagnostics Reports First Quarter 2016 Financial Results 43
Mar 08, 2016: Chembio Diagnostics Reports 2015 Financial Results 45
Corporate Communications 47
Aug 17, 2017: Chembio Diagnostics Announces Retirement of Chief Financial Officer 47
Jul 06, 2017: Gail S. Page Joins Chembio Diagnostics Board of Directors 48
Jan 26, 2017: Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific 49
Oct 11, 2016: Chembio Expands Global Commercial Operations Leadership 50
Other Significant Developments 51
Sep 08, 2017: Ginolis Rapid Test Assembly System Selected by Chembio Diagnostics 51
Sep 23, 2016: Chembio Expands Exclusive Distribution Agreements with Isla Lab to Include Puerto Rico and U.S. Virgin Islands 52
Aug 25, 2016: Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus 53
Feb 19, 2016: Chembio Awarded Grant From Paul G. Allen Family Foundation to Develop Point-of-Care Diagnostic Tests for Zika Virus and Related Febrile Illnesses 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Chembio Diagnostic, Inc., Medical Equipment, Key Facts, 2016 2
Chembio Diagnostic, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Chembio Diagnostic, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Chembio Diagnostic, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 7
Chembio Diagnostic, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Chembio Diagnostic, Inc., Deals By Market, 2011 to YTD 2017 9
Chembio Diagnostic, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Chembio Diagnostics Acquires Rights to SURE CHECK(R) HIV 1/2 Assay From StatSure Diagnostic Systems 11
Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 12
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 13
Chembio Diagnostics Enters into Agreement with FIND 14
Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 15
Chembio Diagnostics Enters into Agreement with Perseus Science 16
Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 17
Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 18
Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 19
Chembio Diagnostics to Raise up to USD21.2 Million in Public Offering of Shares 20
Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 21
Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million 23
Chembio Diagnostics Acquires RVR Diagnostics 24
Chembio Diagnostic, Inc., Key Competitors 25
Chembio Diagnostic, Inc., Key Employees 26
Chembio Diagnostic, Inc., Subsidiaries 27

★調査レポート[Chembio Diagnostic, Inc. (CEMI)-医療機器分野:企業M&A・提携分析] (コード:DATA8013816)販売に関する免責事項を必ずご確認ください。
★調査レポート[Chembio Diagnostic, Inc. (CEMI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆